Pritzker Private Capital Acquires Majority Stake in Americhem

US investment company Pritzker Private Capital (PPC) has agreed to acquire a majority stake in Americhem, a family-owned US manufacturer of custom color masterbatch, performance additive and engineered compound solutions.

Founded in 1941 and headquartered in Cuyahoga Falls, Ohio, Americhem develops and manufactures color masterbatch and custom compound solutions that are necessary for the durability, quality and aesthetic of end products across a variety of markets including healthcare, fiber, transportation and building products.

Americhem has a diversified base of more than 1,500 customers globally and operates ten manufacturing plants with approximately 1,000 employees and sales offices located throughout North America, Europe and Asia. According to a statement from both companies, there will be no changes to Americhem’s current leadership team.

“We have long admired Americhem for its track record of success and its essential role in the value chain across its end markets,” said Kaitlyn Desai, principal at PCC. “We are very familiar with this sector and see many opportunities to build on Americhem’s strong foundation, accelerate growth and achieve sustained success together.”

“PPC is the ideal partner for Americhem’s next phase of growth and, importantly, the PPC team shares our core values of purpose, collaboration and continuous improvement,” said Rick Juve, chairman of Americhem.

John Richard, CEO at Americhem, added: “With PPC as our partner, I am confident in our trajectory to accelerate growth, expand R&D and innovation, and enhance our ability to solve our customers’ most complex challenges.”

Terms of the transaction, which is subject to customary closing conditions and is expected to close in the first quarter 2025, were not disclosed.

© XXLPhoto/Shutterstock
© XXLPhoto/Shutterstock

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

most read

Photo
21.03.2025 • News

What’s Next for Pharma Supply Chains?

Sudden shifts in demand, supply shortages and global collapse have put immense pressure on pharmaceutical logistics. To address these challenges, PHARMAP 2025 brings together industry experts to discover AI-driven supply chain optimisation, strategic logistics partnerships and digital solutions that enhance efficiency and resilience in the pharmaceutical supply chain.